RAB39B and diffuse large B-cell lymphoma: Our results showed that increased RAB39B expression was associated with decreased sensitivity of commonly used chemotherapy drugs such as dexamethasone, doxorubicin, etoposide, vincristine, and cytarabine and poor OS in DLBCL.